D164VWC Virtuoso VR
Implantable Cardioverter Defibrillator (ICD)
D164VWC Virtuoso VR
Information

Device Survival Probability

D154VWC,D164VWC_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr 11 yr 12 yr 13 yr 14 yr 15 yr            
% Excluding Normal Battery Depletion 100.0 100.0 99.9 99.7 98.1 96.8 96.7 96.6 96.5 96.5 96.4 96.4 96.4 96.4 96.3            
% Including Normal Battery Depletion 99.8 99.6 99.3 98.8 96.0 87.7 77.5 60.3 44.4 31.9 22.8 18.0 16.3 15.2 14.2            
#   28535 26124 23730 21531 19161 16195 13286 9329 6103 3950 2478 1605 1153 849 126            
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Customer Communications For This Model

  • There are no communications for this model.
Information

Product Characteristics

Generator Type ICD
NBD Code VVE-VVIR
Max. Delivered Energy 35 J
More
Connector Style Cx Style
Serial Number Prefix PUP
Mass 68 g
Volume 37 cc
Waveform Biphasic
X-Ray ID PVR
Hide this content
Cx Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 4.8 5.1 5.3 5.4
Quarterly 8.1 9.0 9.6 10.0
Semi-annual 10.0 11.2 12.3 12.9
Footnote

Longevity estimates based on the following device usage. Pacing Mode VVI; Ventricular Lower Pacing Rate 60ppm; Ventricular Pulse Width 0.4ms; Ventricular Pulse Amplitude 3V; Ventricle Impedance 510ohms; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

Distribution Data

US Market Release
CE Approval Date2006-03-07
Registered USA Implants1
Estimated Active USA Implants1
Normal Battery Depletions
US Market Release
CE Approval Date2006-03-07
Estimated WW Distribution14374
Normal Battery Depletions268
Information

Malfunctions (USA)

Therapy Function Not Compromised
Therapy Function Compromised
Information

Malfunctions (WW)

Therapy Function Not Compromised 424
Battery 5
Electrical Component 413
Possible Early Battery Depletion 3
Software/Firmware 1
Other 2
Therapy Function Compromised 13
Battery 1
Electrical Component 12
Information

EOS Indication

EOS device status is defined as 3 months following an RRT indication assuming the following PSP conditions: 100% VVI pacing at 60 min-1, 2.5 V, 0.4 ms; 500 Ohm pacing load; and 6 full-energy charges. EOS may be indicated before the end of 3 months if the device exceeds these conditions.

Information

Recommended Replacement (RRT)

Battery voltage less than or equal to 2.62V on 3 consecutive daily automatic measurments.

Information

Charge Time

D154VWC_D164VWC_CHRG
Loading...

Data as of December 1, 2023

www.medtronic.com/productperformance 951051